Skip to content

Effect of Vitamin E and Pioglitazone in patients with non-alcoholic fatty liver disease

Effect of Vitamin E and Pioglitazone in patients with non-alcoholic fatty liver disease in Marvdasht Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705016312N4
Enrollment
90
Registered
2017-05-20
Start date
2017-05-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver. Nonalcoholic steatohepatitis

Interventions

Intervention 1: Intervention group: lifestyle modification and Vitamin E 400IU/day for 3 months. Intervention 2: Intervention group: lifestyle modification and pioglitazone 15 mg/day for 3 months. Int
Treatment - Drugs
Intervention group: lifestyle modification and Vitamin E 400IU/day for 3 months
Intervention group: lifestyle modification and pioglitazone 15 mg/day for 3 months
Control group: lifestyle modification and placebo for 3 months

Sponsors

Vice chancellor for research, Shiraz University Of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients with NAFLD confirmed by performing liver sonography and increased levels of liver enzymes AST and ALT. Exclusion Criteria: History of alcohol consumption; diabetes; chronic liver disease; use of drugs such as statin, fibrate.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Liver function test. Timepoint: Before intervention - 3 months after intervention. Method of measurement: ELISA.

Secondary

MeasureTime frame
Body Mass Index. Timepoint: Before intervention - 3 months after intervention. Method of measurement: By BMI Formula.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Hadadi

International branch_Shiraz University of Medical Sciences

hadadi.niloufar@gmail.com+98 71 3623 4504

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026